Purchase Order 36C26126P0255

The U.S. Department of Veterans Affairs, through Veterans Integrated Service Network 21, awarded a $32.5K firm fixed-price purchase order to Edwards Lifesciences LLC for transcatheter aortic valve replacement (TAVR) surgical implants restocking. This contract, awarded December 29, 2025, with an ultimate completion date of March 28, 2026, supports the VA's mission to provide advanced cardiovascular care to veterans at the San Francisco facility. No set-aside designation was utilized for this award. Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a recognized leader in structural heart disease medical devices, serves as the sole source provider of specialized cardiac implants to the VA across multiple service networks.

This purchase order represents a continuation of Edwards Lifesciences LLC's established role as a critical supplier of advanced cardiovascular technologies to the federal healthcare system. The vendor's specialized expertise in transcatheter heart valves and surgical implants aligns directly with the VA's need to maintain inventory of short shelf-life medical devices required for complex cardiac surgical procedures. As a self-certified small disadvantaged business, Edwards Lifesciences LLC complements its sole-source indefinite delivery contracts with the VA—valued at $2.5M and $1.25M respectively—through targeted restocking purchase orders that ensure veteran beneficiaries have timely access to state-of-the-art cardiac treatment options.